NCT07241325

Brief Summary

This prospective cross-sectional observational study aims to explore the relationships among psychological well-being, depression, and quality of life in patients with type 2 diabetes attending the outpatient metabolic clinic at National Taiwan University Hospital. The study will collect data using standardized instruments, including the EQ-5D Health-Related Quality of Life Questionnaire, the PHQ-9 Depression Scale, and the Shalom Scale of Psychological Well-Being, along with demographic and clinical variables such as age, sex, education, body mass index, HbA1c, disease duration, and psychosocial support indicators. Descriptive statistics, Pearson correlation analyses, ANOVA, and multiple linear regression modeling will be performed to identify factors associated with psychological well-being. The findings are expected to provide evidence-based insights to inform tailored interventions and improve the mental health and quality of life of patients with type 2 diabetes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
5mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress61%
Sep 2025Oct 2026

Study Start

First participant enrolled

September 19, 2025

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

September 24, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 21, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Last Updated

January 28, 2026

Status Verified

December 1, 2025

Enrollment Period

9 months

First QC Date

September 24, 2025

Last Update Submit

January 26, 2026

Conditions

Keywords

Type 2 Diabetes MellitusPsychological Well-BeingDepressionPHQ-9EQ-5D-5LShalom ScaleSpiritual Well-BeingPsychosocial SupportCross-SectionalObservationalTaiwan

Outcome Measures

Primary Outcomes (1)

  • Shalom Scale Total Score (Psychological Well-Being)

    The Shalom Scale for Psychological Well-Being will be used to measure psychological well-being. Higher scores indicate better spiritual/psychological well-being. The total score will be analyzed as a continuous variable.

    At enrollment (single outpatient visit; questionnaires completed in approximately 30-40 minutes).

Secondary Outcomes (3)

  • PHQ-9 Total Score (Depression Severity)

    Day 1

  • EQ-5D-5L Index Score (Health Utility)

    Day 1

  • EQ-5D-5L Visual Analog Scale (VAS)

    Day 1

Other Outcomes (2)

  • Associations Between Demographic/Clinical Variables and Psychological Well-Being

    Day 1

  • Exploratory Subgroup Analyses of Psychological Well-Being, Depression, and Quality of Life

    Day 1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients (aged 18 years and older) with a confirmed diagnosis of type 2 diabetes mellitus receiving ongoing outpatient care at the Metabolism Clinic of National Taiwan University Hospital. Approximately 350 participants will be recruited using convenience sampling during routine clinic visits. All participants must be able to read and understand Chinese questionnaires, complete self-administered forms, and provide written informed consent. The study does not include healthy volunteers or individuals without type 2 diabetes.

You may qualify if:

  • Adults aged 18 years or older with full legal capacity.
  • Clinically diagnosed with Type 2 Diabetes Mellitus and receiving ongoing outpatient care.
  • Able to read and understand Chinese questionnaires and complete self-administered forms.
  • Understand the study purpose and procedures and provide written informed consent.

You may not qualify if:

  • Presence of major psychiatric disorders (e.g., schizophrenia, bipolar disorder, major depressive disorder).
  • Moderate to severe cognitive impairment or dementia, as assessed by the clinical physician, making it impossible to complete the questionnaires.
  • Currently experiencing acute diabetic complications (e.g., diabetic ketoacidosis, hyperosmolar hyperglycemic state) or hospitalization.
  • Severe language or other communication barriers preventing expression of consent or understanding of study content.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital - Metabolism

Taipei, 100229, Taiwan

RECRUITING

Related Publications (3)

  • Shalom S., Wang Y.T., Wang C.H., Hu R.Z. (2013). Development and validation of the Shalom Scale for psychological well-being in Chinese populations. Fu Jen Medical Journal, 11(3), 197-204.

    RESULT
  • EuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990 Dec;16(3):199-208. doi: 10.1016/0168-8510(90)90421-9.

  • Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2DepressionPsychological Well-Being

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehavioral SymptomsBehaviorPersonal Satisfaction

Study Officials

  • Ching-Yuan Wang

    National Taiwan University Hospital, Department of Internal Medicine (Metabolism)

    PRINCIPAL INVESTIGATOR

Central Study Contacts

YI-CHIEH CHUNG, MSN, RN

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 24, 2025

First Posted

November 21, 2025

Study Start

September 19, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

January 28, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

De-identified individual participant data that may be shared include questionnaire scores and coded demographic and clinical variables (e.g., age group, sex, diabetes duration, BMI category, HbA1c range, presence of complications). No directly identifiable information (such as names, ID numbers, or contact information) will be included. Data will be stored and shared only under institutional data-sharing agreements, following approval by the National Taiwan University Hospital Research Ethics Committee.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Beginning 12 months after publication of the main results; available for up to 5 years thereafter.
Access Criteria
Qualified researchers may request access by submitting a written proposal and institutional data-sharing agreement to the Principal Investigator. Approval will be required from the National Taiwan University Hospital Research Ethics Committee prior to data release.
More information

Locations